Is the Combination of Sulfonylureas and Metformin Associated with an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: a Meta-Analysis of Observational Studies
Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)
Indulgent Yet Balanced: High in protein, seed oil-free, soy-free and made with real ingredients, but tastes like something youd expect from your favourite restaurant
Semaglutide is a second-generation injectable medication, which will eventually replace the first-generation liraglutide (Saxenda, Victoza)